Epilepsy – new possibilities of pharmacological therapy
Epilepsy is one of the most common neurological diseases. Due to its characteristics it is a serious medical and social problem, but in the majority of patients can be successfully treated. Recommendations for successful treatment are: defining the clinical phenotype or epileptic syndrome as good as possible, starting the proper antiepileptic therapy with optimal dosage as early as possible, and to pay special attention to a specific population of women of childbearing age and patients in older age groups, due to the physiological specificity, comorbidities as well as altered mechanism of action of antiepileptic drugs, and co-administered therapy and possible interactions with antiepileptic drugs. Following these recommendations approximately 70-80% of patients’ remission is achieved. The remaining so-called pharmacoresistant patients continue to have seizures despite their regular therapy and are candidates for neurosurgical treatment. The newer antiepileptic drugs have led to more treatment options, but they have not significantly reduced the incidence of patients with refractory epilepsy.
Key words:
antiepileptics, indications, interaction; epilepsy; specific populations





